WO1999029890A3 - Assessment of human papilloma virus-related disease - Google Patents

Assessment of human papilloma virus-related disease Download PDF

Info

Publication number
WO1999029890A3
WO1999029890A3 PCT/US1998/026447 US9826447W WO9929890A3 WO 1999029890 A3 WO1999029890 A3 WO 1999029890A3 US 9826447 W US9826447 W US 9826447W WO 9929890 A3 WO9929890 A3 WO 9929890A3
Authority
WO
WIPO (PCT)
Prior art keywords
assessment
related disease
papilloma virus
human papilloma
hpv infection
Prior art date
Application number
PCT/US1998/026447
Other languages
French (fr)
Other versions
WO1999029890A2 (en
Inventor
Attila T Lorincz
Original Assignee
Digene Corp
Attila T Lorincz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27371534&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1999029890(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AU19117/99A priority Critical patent/AU746061B2/en
Priority to EP98963881A priority patent/EP1038022B1/en
Priority to BR9814271-2A priority patent/BR9814271A/en
Priority to AT98963881T priority patent/ATE299946T1/en
Priority to JP2000524461A priority patent/JP2001526045A/en
Application filed by Digene Corp, Attila T Lorincz filed Critical Digene Corp
Priority to CA2313483A priority patent/CA2313483C/en
Priority to DE69830927T priority patent/DE69830927T2/en
Publication of WO1999029890A2 publication Critical patent/WO1999029890A2/en
Publication of WO1999029890A3 publication Critical patent/WO1999029890A3/en
Priority to NO20002979A priority patent/NO330906B1/en
Priority to AU2002300070A priority patent/AU2002300070B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/708Specific hybridization probes for papilloma
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development

Abstract

This invention provides novel methods for assessing HPV infection. Gene expression levels are used to the progression of HPV infection from benign to malignant growth by determining the ratio between mRNA levels of E6 and/or E7 and E2 and/or L1. Also provided are kits for carrying out the methods of this invention.
PCT/US1998/026447 1997-12-12 1998-12-11 Assessment of human papilloma virus-related disease WO1999029890A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE69830927T DE69830927T2 (en) 1997-12-12 1998-12-11 EVALUATION OF HUMAN PAPILLOMVIRUS OF RELATED DISEASE
EP98963881A EP1038022B1 (en) 1997-12-12 1998-12-11 Assessment of human papilloma virus-related disease
BR9814271-2A BR9814271A (en) 1997-12-12 1998-12-11 Determination of diseases related to human papilloma virus
AT98963881T ATE299946T1 (en) 1997-12-12 1998-12-11 EVALUATION OF HUMAN PAPILLOMA VIRUS-RELATED DISEASE
JP2000524461A JP2001526045A (en) 1997-12-12 1998-12-11 Evaluation of human papillomavirus-related diseases
AU19117/99A AU746061B2 (en) 1997-12-12 1998-12-11 Assessment of human papilloma virus-related disease
CA2313483A CA2313483C (en) 1997-12-12 1998-12-11 Assessment of human papilloma virus-related disease
NO20002979A NO330906B1 (en) 1997-12-12 2000-06-09 In vitro method for the detection of high risk HPV induced cell transformation and its use
AU2002300070A AU2002300070B2 (en) 1997-12-12 2002-07-11 Assessment of Human Papilloma Virus-Related disease

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6942697P 1997-12-12 1997-12-12
US60/069,426 1997-12-12
US7048698P 1998-01-05 1998-01-05
US60/070,486 1998-01-05
US8216798P 1998-04-17 1998-04-17
US60/082,167 1998-04-17

Publications (2)

Publication Number Publication Date
WO1999029890A2 WO1999029890A2 (en) 1999-06-17
WO1999029890A3 true WO1999029890A3 (en) 1999-09-10

Family

ID=27371534

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US1998/026447 WO1999029890A2 (en) 1997-12-12 1998-12-11 Assessment of human papilloma virus-related disease
PCT/US1998/026342 WO1999031273A2 (en) 1997-12-12 1998-12-11 Universal collection medium

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US1998/026342 WO1999031273A2 (en) 1997-12-12 1998-12-11 Universal collection medium

Country Status (13)

Country Link
US (5) US6969585B2 (en)
EP (2) EP1038022B1 (en)
JP (3) JP2002508190A (en)
AT (1) ATE299946T1 (en)
AU (2) AU748022B2 (en)
BR (2) BR9814272A (en)
CA (2) CA2313641A1 (en)
DE (1) DE69830927T2 (en)
DK (1) DK1038022T3 (en)
ES (1) ES2246546T3 (en)
NO (2) NO330906B1 (en)
PT (1) PT1038022E (en)
WO (2) WO1999029890A2 (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508190A (en) * 1997-12-12 2002-03-19 ダイジーン・コーポレーション Universal collection medium
KR20020064298A (en) 1999-10-13 2002-08-07 시쿼넘, 인코포레이티드 Methods for generating databases and databases for identifying polymorphic genetic markers
KR100382703B1 (en) * 2000-03-15 2003-05-09 주식회사 바이오메드랩 diagnosis kit for genotyping of Human Papillomavirus and manufacturing method for thereof
WO2001073135A2 (en) * 2000-03-28 2001-10-04 Biosearch International Pty. Ltd. Approaches for hpv detection and staging by targeting the e6 gene region of the viral genome
AU2001256976A1 (en) * 2000-04-03 2001-10-15 Cytyc Corporation Detection and typing of human papillomavirus using pna probes
US20040115692A1 (en) * 2000-04-03 2004-06-17 Cytyc Corporation Methods, compositions and apparatuses for detecting a target in a preservative solution
IT1316070B1 (en) * 2000-05-05 2003-03-28 Bioanalisi Ct Sud Snc Di Perse METHOD AND MEANS FOR IDENTIFICATION OF VIRUS HPV
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
CA2414102A1 (en) * 2000-06-21 2001-12-27 Digene Corporation Universal collection medium
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US20040121310A1 (en) * 2002-12-18 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in forensic studies
KR100437626B1 (en) * 2001-06-21 2004-06-26 주식회사 마이진 Methods for Dectecting Human Papillomavirus and Detection Kit Thereof
MXPA04006440A (en) 2002-01-07 2005-03-31 Norchip As Method for detecting human papillomarvirus mrna.
AU2003284239B2 (en) 2002-10-21 2008-08-21 Eisai Inc. Compositions and methods for treating human papillomavirus-mediated disease
EP1464709B1 (en) * 2003-03-31 2007-12-26 Stichting Researchfonds Pathologie Detection of HPV-induced invasive cancers and their precursor lesions with invasive potential
US20040203004A1 (en) * 2003-04-10 2004-10-14 Bernard Hans Ulrich Diagnostic apparatus and method
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
WO2005008248A2 (en) * 2003-07-18 2005-01-27 Georgetown University Diagnosis and treatment of cervical cancer
EP1510820B1 (en) * 2003-08-25 2010-03-17 MTM Laboratories AG Method for detecting medically relevant conditions in a solubilized LBC sample
DE60300339T2 (en) 2003-08-25 2006-04-13 Mtm Laboratories Ag Method for the detection of carcinomas in solubilized cervical body samples
US7482142B1 (en) 2004-05-07 2009-01-27 Roche Molecular Systems, Inc. High-risk human papillomavirus detection
US7316904B1 (en) 2004-06-30 2008-01-08 Chromodynamics, Inc. Automated pap screening using optical detection of HPV with or without multispectral imaging
KR100572721B1 (en) * 2004-07-26 2006-04-24 이미영 RNA preservation medium comprising cathodic electrolyzed water and method of preserving RNA using the same
AU2005314061B2 (en) 2004-12-08 2010-01-28 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
GB0500996D0 (en) * 2005-01-18 2005-02-23 Delfts Diagnostic Labaratory B Detection method and materials therefor
US7524631B2 (en) * 2005-02-02 2009-04-28 Patterson Bruce K HPV E6, E7 mRNA assay and methods of use thereof
US20070111960A1 (en) * 2005-03-04 2007-05-17 Advandx, Inc. High affinity probes for analysis of human papillomavirus expression
DE102005015005A1 (en) * 2005-04-01 2006-10-05 Qiagen Gmbh Process for treating a sample containing biomolecules
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
ATE478966T1 (en) * 2006-06-19 2010-09-15 Becton Dickinson Co METHODS AND COMPOSITIONS FOR OBTAINING AMPLIFIABLE NUCLEIC ACIDS FROM TISSUES, CELLS OR VIRUSES EXPOSED TO TRANSPORT MEDIA
US8012685B2 (en) * 2006-08-01 2011-09-06 Applied Biosystems, Llc Detection of analytes and nucleic acids
US8865162B2 (en) * 2008-06-13 2014-10-21 Oncohealth Corp. Monoclonal antibodies against HPV proteins
WO2010129821A1 (en) 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100285443A1 (en) * 2006-12-15 2010-11-11 Oncomethylome Sciences Sa Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome
JP5241100B2 (en) * 2006-12-28 2013-07-17 シスメックス株式会社 Antigen activation liquid, antigen activation method, and cell detection method
US20090311392A1 (en) * 2007-09-20 2009-12-17 Paul Bernard Newman Novel approach to the controlled decontamination and or detoxification of nuts, grains, fruits and vegetables
WO2009092017A1 (en) * 2008-01-16 2009-07-23 Medical College Of Georgia Research Institute, Inc. Biomarkers for hpv-induced cancer
JP2011518333A (en) * 2008-04-17 2011-06-23 キアジェン ゲイサーズバーグ インコーポレイテッド Composition, method, and kit using synthetic probe for determining presence of target nucleic acid
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
JP2012506705A (en) 2008-10-27 2012-03-22 キアジェン ゲイサーズバーグ インコーポレイテッド Hybrid capture analysis and system for quick results
EP2184368A1 (en) 2008-11-07 2010-05-12 DKFZ Deutsches Krebsforschungszentrum Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
WO2010064628A1 (en) * 2008-12-05 2010-06-10 オリンパス株式会社 Method for preparing sample containing nucleic acid, solution for preparing sample, and method for analyzing nucleic acid
CN102365055A (en) 2009-01-27 2012-02-29 遗传技术有限公司 Biological sampling device
WO2010088292A1 (en) * 2009-01-28 2010-08-05 Qiagen Gaithersburg, Inc. Sequence-specific large volume sample preparation method and assay
CA2760542A1 (en) 2009-05-01 2010-11-04 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of rna splice-forms in a sample
DK2473596T3 (en) 2009-09-03 2018-01-22 Becton Dickinson Co METHODS AND COMPOSITIONS FOR DIRECT CHEMICAL LYSIS
AU2010291990B2 (en) 2009-09-14 2016-05-05 Qiagen Gaithersburg, Inc. Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
CN102803490B (en) * 2010-01-04 2015-03-25 奇亚根盖瑟斯堡股份有限公司 Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers
CN102822189B (en) * 2010-01-29 2016-06-29 奇亚根盖瑟斯堡股份有限公司 The method and composition of (multiplex analysis) is analyzed for the sequence-specific purification of nucleic acid and MULTIPLE COMPOSITE body
BR112012018545A2 (en) 2010-01-29 2016-05-03 Qiagen Gaithersburg Inc method of determining and confirming the presence of an hpv in a sample
CA2799200A1 (en) 2010-05-19 2011-11-24 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
JP6153866B2 (en) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー. Rapid hybrid capture assay and associated strategically cleaved probe
US9885092B2 (en) 2011-02-24 2018-02-06 Qiagen Gaithersburg Inc. Materials and methods for detection of HPV nucleic acids
US20140127745A1 (en) * 2011-06-24 2014-05-08 Biotechnology Developers, S.A. Method, compositions and device for preparing cytological specimens
EP2773745B1 (en) 2011-11-03 2019-04-10 QIAGEN Gaithersburg, Inc. Materials and method for immobilizing, isolating, and concentrating cells using carboxylated surfaces
JP5960421B2 (en) * 2011-12-05 2016-08-02 株式会社日立ハイテクノロジーズ Cell measuring method and cell measuring reagent
CN104394774B (en) 2012-04-28 2018-03-09 塞托克尔公司 Method, packaging and device for biological specimen from collection
US8734364B1 (en) 2013-11-07 2014-05-27 Genetic Technologies Limited Device and method for obtaining a biological sample
WO2016005789A1 (en) 2014-07-07 2016-01-14 Institut Pasteur Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus- associated cancer stages
CN107250346B (en) 2015-06-30 2019-11-15 希森美康株式会社 The manufacturing method of cell-preservation liquid and its utilization and cell-preservation liquid
MA46354A (en) 2016-10-03 2019-08-07 Juno Therapeutics Inc MOLECULES BINDING SPECIFICALLY TO HPV
MA50613A (en) 2017-10-03 2020-08-12 Editas Medicine Inc HPV-SPECIFIC BINDING MOLECULES
PE20201345A1 (en) 2018-04-05 2020-11-25 Juno Therapeutics Inc RECEIVERS OF T-CELLS, AND DESIGNED CELLS THAT EXPRESS THEM
PL240016B1 (en) * 2019-09-09 2022-02-07 Genomtec Spolka Akcyjna Set of primers for the detection of human papillomavirus type 16 (HPV16 Human papillomavirus type 16) and human papillomavirus type 18 (HPV18 Human papillomavirus type 18), method of detecting HPV16 and HPV18 infections, the application of a set of primers for the detection of HPV16 and HPV18 infections
US20230087422A1 (en) * 2020-02-07 2023-03-23 Isa Pharmaceuticals B.V. Treatment of hpv-related diseases
WO2023081900A1 (en) 2021-11-08 2023-05-11 Juno Therapeutics, Inc. Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991008312A1 (en) * 1989-12-01 1991-06-13 Gene-Trak Systems Detection of hpv transcripts
US5543294A (en) * 1991-07-19 1996-08-06 The Trustees Of Columbia University In The City Of New York Polymerase chain reaction/restriction fragment length polymorphism method for the detection and typing of myobacteria

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732847A (en) * 1981-06-09 1988-03-22 University Of Hawaii Monoclonal antibodies for DNA-RNA hybrid complexes and their uses
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
US4578282A (en) * 1982-02-04 1986-03-25 Harrison James S Composition for diagnostic reagents
US4465078A (en) 1982-09-30 1984-08-14 Medtest Corporation Method for cell sampling in a body cavity
US4865980A (en) * 1982-12-29 1989-09-12 University Of Hawaii Monoclonal antibodies for DNA-RNA hybrid complexes and their uses
ATE167524T1 (en) * 1983-01-10 1998-07-15 Gen Probe Inc METHOD FOR DETECTING, IDENTIFYING AND QUANTIFYING ORGANISMS AND VIRUSES
US5288611A (en) * 1983-01-10 1994-02-22 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US5200313A (en) * 1983-08-05 1993-04-06 Miles Inc. Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
EP0144914A3 (en) 1983-12-12 1986-08-13 Miles Inc. Hybridization assay employing labeled pairs of hybrid binding reagents
US4743535A (en) * 1984-11-07 1988-05-10 Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
AU3844485A (en) * 1984-02-09 1985-08-15 Enzo Biochem Inc. Heterologous detection of cabeled dna
FI71768C (en) * 1984-02-17 1987-02-09 Orion Yhtymae Oy Enhanced nucleic acid reagents and process for their preparation.
US6221581B1 (en) * 1984-04-27 2001-04-24 Enzo Diagnostics, Inc. Processes for detecting polynucleotides, determining genetic mutations or defects in genetic material, separating or isolating nucleic acid of interest from samples, and useful compositions of matter and multihybrid complex compositions
CA1260372A (en) * 1984-04-27 1989-09-26 Elazar Rabbani Hybridization method for the detection of genetic materials
CA1253777A (en) 1984-06-01 1989-05-09 Robert J. Carrico Nucleic acid hybridization assay employing immobilized rna probes
ZA853756B (en) 1984-06-01 1986-01-29 Miles Lab Nucleic acid hybridization assay employing immobilized rna probes
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4775619A (en) * 1984-10-16 1988-10-04 Chiron Corporation Polynucleotide determination with selectable cleavage sites
US5641630A (en) * 1985-06-13 1997-06-24 Amgen Inc. Method and kit for performing nucleic acid hybridization assays
US4751177A (en) * 1985-06-13 1988-06-14 Amgen Methods and kits for performing nucleic acid hybridization assays
US4888278A (en) 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5750338A (en) * 1986-10-23 1998-05-12 Amoco Corporation Target and background capture methods with amplification for affinity assays
IL85551A0 (en) 1987-04-01 1988-08-31 Miles Inc Rapid hybridization assay and reagent system used therein
GB8717169D0 (en) * 1987-07-21 1987-08-26 Ti Interlock Ltd Pneumatic control system
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5656731A (en) * 1987-10-15 1997-08-12 Chiron Corporation Nucleic acid-amplified immunoassay probes
US5082830A (en) * 1988-02-26 1992-01-21 Enzo Biochem, Inc. End labeled nucleotide probe
US6326136B1 (en) * 1988-04-01 2001-12-04 Digene Corporation Macromolecular conjugate made using unsaturated aldehydes
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
CA2049043A1 (en) * 1989-03-10 1990-09-11 Mark L. Collins Immobilized oligo-nucleotide probes and uses therefor
US5106727A (en) * 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
DE69032847T2 (en) * 1989-06-30 1999-05-12 Chiron Corp Hydrophobic nucleic acid probe
US5116734A (en) * 1989-09-01 1992-05-26 Digene Diagnostics, Inc. Highly sensitive method for detecting peroxidase
US5580970A (en) 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
US5629153A (en) * 1990-01-10 1997-05-13 Chiron Corporation Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
US5792606A (en) * 1990-02-26 1998-08-11 Boehringer Mannheim Gmbh Nucleic acid hybridization based assay for determining a substance of interest
CA2039517C (en) * 1990-04-03 2006-11-07 David Segev Dna probe signal amplification
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
US5484699A (en) * 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
US5474895A (en) * 1990-11-14 1995-12-12 Siska Diagnostics Inc. Non-isotopic detection of nucleic acids using a polystyrene support-based sandwich hybridization assay and compositions useful therefor
US5256571A (en) 1991-05-01 1993-10-26 Cytyc Corporation Cell preservative solution
US5556748A (en) * 1991-07-30 1996-09-17 Xenopore Corporation Methods of sandwich hybridization for the quantitative analysis of oligonucleotides
DE69230693T2 (en) * 1991-11-14 2000-06-15 Dgi Inc NON-RADIOACTIVE HYBRIDIZATION TEST METHOD AND SET
US5981179A (en) * 1991-11-14 1999-11-09 Digene Diagnostics, Inc. Continuous amplification reaction
JPH07502653A (en) * 1991-12-23 1995-03-23 カイロン コーポレイション HBV amplification probe for use in solution phase sandwich hybridization assays
US5747244A (en) * 1991-12-23 1998-05-05 Chiron Corporation Nucleic acid probes immobilized on polystyrene surfaces
US5424413A (en) * 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
IL106273A0 (en) 1992-07-17 1993-11-15 Res Dev Foundation Rapid detection of biopolymers in stained specimens
EP0625213B1 (en) * 1992-10-09 1999-12-29 VYSIS, Inc. Assay methods
EP0688366B1 (en) * 1993-01-15 2002-05-22 The Public Health Research Institute Of The City Of New York, Inc. Sensitive nucleic acid sandwich hybridization assays and kits
US5357977A (en) * 1993-04-23 1994-10-25 St. Mary's Hospital And Medical Center, Inc. Cytological sampling method and device
WO1994028156A1 (en) * 1993-05-20 1994-12-08 Dana-Farber Cancer Institute Compositions and methods for treatment of herpesvirus infections
AU689789B2 (en) * 1993-07-23 1998-04-09 Gen-Probe Incorporated Methods for enhancing nucleic acid amplification
DE4331012A1 (en) * 1993-09-13 1995-03-16 Bayer Ag Nucleic acid-binding oligomers with N-branching for therapy and diagnostics
US5370128A (en) 1993-12-02 1994-12-06 Wainwright; Sharon R. Pap brush and pap unit container systems
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
JP3738910B2 (en) * 1994-04-04 2006-01-25 バイエル コーポレーション Hybridization-ligation analysis to detect specific nucleic acid sequences
CA2126952C (en) * 1994-06-28 2010-12-14 Sithian Pandian Probe, kit, and method of amplification for increasing the sensitivity of nucleic acid hybridization assays
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
JP3093116B2 (en) * 1994-09-30 2000-10-03 株式会社豊田中央研究所 Nucleic acid detection method
US6057099A (en) * 1994-12-02 2000-05-02 Intelligene Ltd. Detection of nucleic acid sequences
US5747248A (en) * 1994-12-05 1998-05-05 Chiron Corporation Discontinuous probe design using hybritope mapping
DE4445769C1 (en) * 1994-12-21 1995-11-09 Biochrom Kg Protective media for storing vital tissues
CA2139070C (en) * 1994-12-23 2010-03-30 Burton W. Blais Method for enhancing detection ability of nucleic acid assays employing polymerase chain reaction
US5731153A (en) * 1996-08-26 1998-03-24 The Regents Of The University Of California Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions
US5888724A (en) * 1995-02-17 1999-03-30 The Trustees Of Columbia University In The City Of New York Detection of high oncogenic-risk papilloma virus in high grade cervical lesions and cancers by a PCR/ELISA assay
US6083925A (en) * 1995-06-07 2000-07-04 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines
AU726047B2 (en) * 1995-11-15 2000-10-26 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US5853993A (en) * 1996-10-21 1998-12-29 Hewlett-Packard Company Signal enhancement method and kit
US5679333A (en) * 1996-10-25 1997-10-21 Dunphy; Brian William Formaldehyde-free tissue preservative compositions
US6110676A (en) * 1996-12-04 2000-08-29 Boston Probes, Inc. Methods for suppressing the binding of detectable probes to non-target sequences in hybridization assays
US20020034737A1 (en) * 1997-03-04 2002-03-21 Hyseq, Inc. Methods and compositions for detection or quantification of nucleic acid species
US6043038A (en) * 1998-03-31 2000-03-28 Tularik, Inc. High-throughput screening assays for modulators of primase activity
AU741141B2 (en) * 1997-11-04 2001-11-22 Roche Diagnostics Gmbh Specific and sensitive method for detecting nucleic acids
JP2002508190A (en) * 1997-12-12 2002-03-19 ダイジーン・コーポレーション Universal collection medium
US20030096232A1 (en) * 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US7399589B2 (en) 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US5994079A (en) * 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US6686151B1 (en) * 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US20010055766A1 (en) * 1999-04-02 2001-12-27 Alexander Aristarkhov Immunosorbant assay using branched bis-biotin/avidin/multiple label complex as a detection reagent
US7019822B1 (en) * 1999-04-29 2006-03-28 Mss, Inc. Multi-grade object sorting system and method
US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
US6893819B1 (en) * 2000-11-21 2005-05-17 Stratagene California Methods for detection of a nucleic acid by sequential amplification
US6436662B1 (en) * 2000-04-04 2002-08-20 Digene Corporation Device and method for cytology slide preparation
US6521190B1 (en) * 2000-05-19 2003-02-18 Digene Corporation Cell collection apparatus
AU2001274869A1 (en) * 2000-05-20 2001-12-03 The Regents Of The University Of Michigan Method of producing a dna library using positional amplification
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
CA2414102A1 (en) * 2000-06-21 2001-12-27 Digene Corporation Universal collection medium
US6977148B2 (en) * 2001-10-15 2005-12-20 Qiagen Gmbh Multiple displacement amplification
MX2007008553A (en) * 2005-01-14 2007-09-25 Univ Michigan Systems, methods, and compositions for detection of human papilloma virus in biological samples.
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US20080206777A1 (en) * 2007-02-27 2008-08-28 Nuclea Biomarkers, Llc Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
US7985375B2 (en) * 2007-04-06 2011-07-26 Qiagen Gaithersburg, Inc. Sample preparation system and method for processing clinical specimens
JP2011518333A (en) * 2008-04-17 2011-06-23 キアジェン ゲイサーズバーグ インコーポレイテッド Composition, method, and kit using synthetic probe for determining presence of target nucleic acid
US9090948B2 (en) * 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991008312A1 (en) * 1989-12-01 1991-06-13 Gene-Trak Systems Detection of hpv transcripts
US5543294A (en) * 1991-07-19 1996-08-06 The Trustees Of Columbia University In The City Of New York Polymerase chain reaction/restriction fragment length polymorphism method for the detection and typing of myobacteria

Also Published As

Publication number Publication date
WO1999031273A2 (en) 1999-06-24
US7291455B2 (en) 2007-11-06
US20070154884A1 (en) 2007-07-05
PT1038022E (en) 2005-11-30
AU746061B2 (en) 2002-04-11
DK1038022T3 (en) 2005-10-24
NO20002980L (en) 2000-08-08
WO1999029890A2 (en) 1999-06-17
CA2313483C (en) 2017-12-05
ATE299946T1 (en) 2005-08-15
BR9814271A (en) 2001-03-20
JP2010136729A (en) 2010-06-24
EP1038029A2 (en) 2000-09-27
US20030091992A1 (en) 2003-05-15
JP2002508190A (en) 2002-03-19
JP2001526045A (en) 2001-12-18
AU748022B2 (en) 2002-05-30
WO1999031273A3 (en) 1999-10-07
DE69830927D1 (en) 2005-08-25
BR9814272A (en) 2000-10-03
CA2313483A1 (en) 1999-06-17
ES2246546T3 (en) 2006-02-16
NO20002979D0 (en) 2000-06-09
CA2313641A1 (en) 1999-06-24
NO20002979L (en) 2000-08-09
DE69830927T2 (en) 2006-05-24
US6969585B2 (en) 2005-11-29
AU1911799A (en) 1999-06-28
EP1038022B1 (en) 2005-07-20
US7879546B2 (en) 2011-02-01
AU1723299A (en) 1999-07-05
EP1038022A2 (en) 2000-09-27
US20020127545A1 (en) 2002-09-12
NO20002980D0 (en) 2000-06-09
US20110097708A1 (en) 2011-04-28
US6355424B1 (en) 2002-03-12
NO330906B1 (en) 2011-08-15

Similar Documents

Publication Publication Date Title
WO1999029890A3 (en) Assessment of human papilloma virus-related disease
EP1715062A3 (en) Method for detecting human papillomavirus mRNA
EP0774518A3 (en) Nucleic acid probes complementary to Human Papillomavirus nucleic acid and related methods and kits
WO2002040634A3 (en) Expression miniarrays and uses thereof
EP0955379A3 (en) Analysis of gene expression by display of 3'-end restriction fragments of cDNAs
DE69332642T2 (en) METHODS FOR DETECTING MICROMETASAS IN PROSTATE CANCER
NO970986D0 (en) API determination using fluorescence measurements
EP1108789A3 (en) Quantitation of hTERT mRNA Expression
AU2174392A (en) Adn sequences of the human papillomavirus type 42, and diagnostic application thereof
BR9710919A (en) Purified protein sr-p70
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
EP0690124A3 (en) Alcohol removal procedure for alcoholic beverages and low alcoholic grading beverages obtained thereby
SE9900615L (en) Method and kit for early prediction of cancer
HUP0100126A2 (en) Chimeric pre-activated transcription factors
WO1999058665A3 (en) Isolation and use of fetal urogenital sinus expressed sequences
WO2002012541A3 (en) Novel motor proteins and methods for their use
DE69912453D1 (en) METHODS AND MATERIALS FOR DIAGNOSIS OF UNSTABLE ANGINA
WO2003036299A8 (en) Procedure for quantitative determination of viral or bacterial particles having a cholesterol-containing envelope
WO2002074908A3 (en) Methods and reagents for regulating apoptosis
MX9605514A (en) Human papilloma virus inhibition by a hairpin ribozyme.
WO2001062964A3 (en) A genetic determinant for malignant melanoma
ATE360704T1 (en) NOVEL PEROXIDASE SUBSTRATES AND THEIR APPLICATION IN CATALYZED REPORTER BINDING ASSAY
WO2003100076A3 (en) Pna probes, probe sets, method and kits pertaining to the determination of listeria
WO2003054227A3 (en) Method for the quantitative determination of gene expression
Stein Bosses From Hell.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA JP NO SG US US US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA JP NO SG US US US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 19117/99

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2313483

Country of ref document: CA

Ref country code: CA

Ref document number: 2313483

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 524461

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998963881

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998963881

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 19117/99

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1998963881

Country of ref document: EP